Stock SLRX SALARIUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Salarius Pharmaceuticals, Inc.

Equities

SLRX

US79400X4043

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-07-05 pm EDT 		5-day change 1st Jan Change
2.275 USD -5.99% Intraday chart for Salarius Pharmaceuticals, Inc. -4.41% -56.25%
Jun. 17 Clinical Data on Salarius Pharmaceuticals? Seclidemstat in Patients with Mds and Cmml Presented At the 2024 European Hematology Association Annual Meeting CI
May. 13 Salarius Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
HC Wainwright Adjusts Salarius Pharmaceuticals' Price Target to $4 From $5, Reiterates Buy Rating
MT
SALARIUS PHARMACEUTICALS : HC Wainwright Starts Salarius Pharmaceuticals at Buy With $5 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SLRX Stock
  4. News Salarius Pharmaceuticals, Inc.
  5. Analyst Reco.